
    
      The study is a randomized, controlled clinical trial. Patients were randomly divided into two
      equal groups, Group I (Test group): included seven Grade II furcation defects treated by beta
      tricalcium phosphate bone cement only.

      Group II (Control group): included seven Grade II furcation defects treated with granulated
      beta tricalcium phosphate bone graft covered by resorbable collagen membrane.
    
  